Methods and systems for determining her2 status using molecular data
AssigneeTempus AI, Inc.
InventorsTalal Ahmed, Raphael Pelossof, Mark Carty, Kaveri Nadhamuni
Life of this patent
Estimating the term…
Loading patent…
AssigneeTempus AI, Inc.
InventorsTalal Ahmed, Raphael Pelossof, Mark Carty, Kaveri Nadhamuni
Estimating the term…
A computer-implemented method, computing system and computer-readable medium for determining HER2-low status of a patient using molecular data of the patient includes: (a) receiving digital biological data; (b) processing the digital biological data using a trained multi-stage machine learning architecture; (c) generating a digital HER2-low status report corresponding to the patient; and (d) causing the digital HER2-low status report to be displayed. A computer-implemented method, computing system and computer-readable medium for training a model architecture to determine HER2-low status of a patient using molecular data of the patient includes: (a) receiving training digital biological data; (b) initializing a machine learning model; (c) processing the plurality of molecular signatures using the machine learning model to generate a trained machine learning model; and (d) storing the trained machine learning.
A computer-implemented method for determining HER2-low status of a patient using molecular data of the patient, comprising:
A computing system comprising:
A computer-readable medium having stored thereon computer-executable instructions that, when executed, cause a computer to:
Dependencies are inferred from the claim text.